Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Anti-ulcer agents

Study finds no support for link between Alzheimer’s disease and PPIs

Researchers conclude that there is no clinically meaningful association between PPI use and risk of Alzheimer’s disease.

Some research has indicated that proton pump inhibitor (PPI) use could increase the risk of dementia.

In a recent study, researchers used national data from Finland to conduct a case-control study of 70,718 people newly diagnosed with Alzheimer’s disease (AD) and 282,858 matched controls.

They found no link between PPI use and risk of AD when they examined a three-year window between exposure and outcome — to reduce the risk of reverse causation (adjusted odds ratio (OR) 1.03, 95% confidence interval (CI) 1.00–1.05). They also found no link between PPI dosage or duration of exposure and AD diagnosis.

Reporting in the American Journal of Gastroenterology (11 July 2017), the team said the results provide no evidence of a clinically meaningful association between PPI use and risk of AD[1].

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203558

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • MRI scan of brain showing Alzheimer's disease

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.